ALX Oncology Holdings Inc. - Ownership Change Reported
Ticker: ALXO · Form: 4 · Filed: Apr 17, 2026 · CIK: 0001810182
Sentiment: neutral
Topics: insider-filing, ownership-change
Related Tickers: ALXO
TL;DR
ALX Oncology insider Barbara Klencke filed a Form 4 showing ownership changes. Details TBD.
AI Summary
On April 16, 2026, Barbara Klencke, a reporting person associated with ALX Oncology Holdings Inc., reported a change in beneficial ownership of securities. The filing details transactions related to her holdings, but specific dollar amounts and the exact nature of the transactions are not detailed in this summary.
Why It Matters
This filing indicates a change in the beneficial ownership of securities for a key person at ALX Oncology Holdings Inc., which could signal shifts in insider confidence or strategy.
Risk Assessment
Risk Level: low — Form 4 filings report changes in beneficial ownership and do not inherently represent a significant risk event without further context on the nature of the transaction.
Key Players & Entities
- Barbara Klencke (person) — Reporting Person
- ALX Oncology Holdings Inc. (company) — Issuer
- 0001810182 (company) — Issuer CIK
- 0001193125-26-161557 (filing_id) — SEC Accession Number
- 2026-04-16 (date) — Period of Report
- 2026-04-17 (date) — Filing Date
FAQ
Who is the reporting person and what is their role at ALX Oncology Holdings Inc.?
The reporting person is Barbara Klencke, identified as a reporting person with CIK 0001647647, and the issuer is ALX Oncology Holdings Inc. (CIK 0001810182).
What is the accession number for this SEC filing?
The SEC Accession No. is 0001193125-26-161557.
When was the period of report for this Form 4 filing?
The period of report was April 16, 2026.
What is the filing date of this Form 4?
The filing date was April 17, 2026.
What is the business address of ALX Oncology Holdings Inc.?
The business address of ALX Oncology Holdings Inc. is 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 17, 2026 by Barbara Klencke regarding ALX ONCOLOGY HOLDINGS INC (ALXO). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.